|
EU News: Joint statement by the EC and DExEU
Further restrictions for multiple sclerosis medicine Zinbryta
EC to invest €30bn in new solutions for societal challenges and breakthrough innovation
How to assess progress on reduction of antimicrobial resistance & antimicrobial consumption
How to develop vaccines & medicines that prevent & treat respiratory syncytial virus (RSV) infection
Pesticides: how can risk assessors make better use of epidemiological data?
|
